Media OutReach The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection Media Outreach|20/06/202321/06/2023oleh RRINEWSS HONG KONG SAR – Media OutReach – 20 June 2023 – On 15 June
